#E2026G01275MAL HAREKETİ ÖZGÜRLÜĞÜ – TIBBİ ÜRÜNLER – EEA EFTA DEVLETLERİ TARAFINDAN 2025 YILININ İLK YARISINDA VERİLEN PAZARLAMA İZİNLERİ LİSTESİ ÜZERİNE ALTKOMİSYON I
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This law outlines the marketing authorizations for medicinal products granted by the EEA EFTA states during the first half of 2025. It affects pharmaceutical companies seeking to sell their products in these regions, ensuring they comply with the necessary regulations. The law aims to facilitate the free movement of goods while maintaining safety standards.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduction of new marketing authorizations for specific medicinal products.
- Streamlined application process for pharmaceutical companies.
- Increased transparency in the approval process.
+ 1 more changes with Pro
Affected Parties
Pharmaceutical companiesRegulatory bodies+2 more…
Tags
medicinal products,marketing authorization,EEA EFTA…